vs
Side-by-side financial comparison of MDxHealth SA (MDXH) and SMITH MIDLAND CORP (SMID). Click either name above to swap in a different company.
SMITH MIDLAND CORP is the larger business by last-quarter revenue ($23.1M vs $19.8M, roughly 1.2× MDxHealth SA).
MDxHealth SA is a global molecular diagnostics company specializing in non-invasive precision oncology tests focused primarily on urological cancers including prostate and bladder cancer. It operates across key markets in North America and Europe, providing clinicians with actionable diagnostic insights to guide personalized treatment decisions, reduce unnecessary invasive procedures, and improve patient care outcomes.
Smith Midland Corp is a specialized manufacturer of precast concrete products for infrastructure, commercial, residential and industrial construction uses. Its key product lines include highway safety barriers, acoustic sound walls, architectural precast panels, and stormwater management systems, serving primarily the North American market with durable, sustainable construction solutions.
MDXH vs SMID — Head-to-Head
Income Statement — Q1 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $19.8M | $23.1M |
| Net Profit | — | $2.1M |
| Gross Margin | 60.8% | 57.5% |
| Operating Margin | -33.3% | 37.8% |
| Net Margin | — | 9.2% |
| Revenue YoY | — | 24.7% |
| Net Profit YoY | — | 52.5% |
| EPS (diluted) | — | $0.41 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $23.1M | ||
| Q3 25 | — | $21.5M | ||
| Q2 25 | — | $26.2M | ||
| Q1 25 | $19.8M | $22.7M | ||
| Q4 24 | — | $18.5M | ||
| Q3 24 | — | $23.6M | ||
| Q2 24 | — | $19.6M | ||
| Q1 24 | $14.7M | $16.8M |
| Q4 25 | — | $2.1M | ||
| Q3 25 | — | $2.9M | ||
| Q2 25 | — | $4.2M | ||
| Q1 25 | — | $3.3M | ||
| Q4 24 | — | $1.4M | ||
| Q3 24 | — | $3.1M | ||
| Q2 24 | — | $2.0M | ||
| Q1 24 | — | $1.1M |
| Q4 25 | — | 57.5% | ||
| Q3 25 | — | 26.8% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | 60.8% | 30.7% | ||
| Q4 24 | — | 51.4% | ||
| Q3 24 | — | 27.9% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | 59.3% | 23.3% |
| Q4 25 | — | 37.8% | ||
| Q3 25 | — | 18.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | -33.3% | 19.3% | ||
| Q4 24 | — | 24.5% | ||
| Q3 24 | — | 16.3% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | -59.3% | 9.0% |
| Q4 25 | — | 9.2% | ||
| Q3 25 | — | 13.4% | ||
| Q2 25 | — | 15.9% | ||
| Q1 25 | — | 14.7% | ||
| Q4 24 | — | 7.5% | ||
| Q3 24 | — | 13.4% | ||
| Q2 24 | — | 10.1% | ||
| Q1 24 | — | 6.8% |
| Q4 25 | — | $0.41 | ||
| Q3 25 | — | $0.54 | ||
| Q2 25 | — | $0.79 | ||
| Q1 25 | — | $0.62 | ||
| Q4 24 | — | $0.28 | ||
| Q3 24 | — | $0.59 | ||
| Q2 24 | — | $0.37 | ||
| Q1 24 | — | $0.21 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | $54.3M |
| Total Assets | — | $87.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $54.3M | ||
| Q3 25 | — | $52.1M | ||
| Q2 25 | — | $49.2M | ||
| Q1 25 | — | $45.1M | ||
| Q4 24 | — | $41.7M | ||
| Q3 24 | — | $40.3M | ||
| Q2 24 | — | $37.2M | ||
| Q1 24 | — | $35.3M |
| Q4 25 | — | $87.7M | ||
| Q3 25 | — | $85.4M | ||
| Q2 25 | — | $81.2K | ||
| Q1 25 | — | $74.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $66.6M | ||
| Q2 24 | — | $64.0M | ||
| Q1 24 | — | $64.9M |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MDXH
Segment breakdown not available.
SMID
| Product Sales | $13.8M | 60% |
| Service Revenue | $9.3M | 40% |
